Literature DB >> 10363645

Modulators of the activation of the proteasome by PA28 (11S reg).

S Wilk1, W E Chen, R P Magnusson.   

Abstract

The degradation of chromogenic substrates and oligopeptides by the 20S proteasome is markedly enhanced and the generation of antigens for presentation by the MHC class-I system is facilitated by combination with an activator protein known as PA28 or 11S reg. We have described the properties of a PA28-proteasome modulator, N-benzyloxycarbonyl-Ile-Glu(O-t-Bu)-Ala-leucinol which shifts the pathway of peptide hydrolysis by the activated proteasome to products terminating in an acidic amino acid at the expense of products terminating in a hydrophobic amino acid. We now report that piperazinyl phenothiazines and several other antipsychotic drugs modulate the PA28-20S activated proteasome in an opposite manner. Fluphenazine, trifluoperazine and prochlorperazine antagonize the peptidylglutamyl peptide bond hydrolyzing activity of the activated proteasome much more strongly than the chymotrypsinlike activity. The chicken ovalbumin immunodominant epitope SIINFEKL is degraded by the activated proteasome to SIINFE and SIINF in approximately equimolar amounts. Piperazinyl phenothiazines promote formation of SIINF whereas Psi-ol promotes formation of SIINFE. PA28- proteasome modulators by modifying the profile of peptides produced by the activated proteasome, may either enhance or suppress the immune response.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10363645     DOI: 10.1023/a:1006955904443

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  20 in total

1.  Identification, purification, and characterization of a protein activator (PA28) of the 20 S proteasome (macropain).

Authors:  C P Ma; C A Slaughter; G N DeMartino
Journal:  J Biol Chem       Date:  1992-05-25       Impact factor: 5.157

2.  Proteasome from Thermoplasma acidophilum: a threonine protease.

Authors:  E Seemüller; A Lupas; D Stock; J Löwe; R Huber; W Baumeister
Journal:  Science       Date:  1995-04-28       Impact factor: 47.728

3.  Molecular cloning and expression of a gamma-interferon-inducible activator of the multicatalytic protease.

Authors:  C Realini; W Dubiel; G Pratt; K Ferrell; M Rechsteiner
Journal:  J Biol Chem       Date:  1994-08-12       Impact factor: 5.157

4.  Cation-sensitive neutral endopeptidase: isolation and specificity of the bovine pituitary enzyme.

Authors:  S Wilk; M Orlowski
Journal:  J Neurochem       Date:  1980-11       Impact factor: 5.372

5.  Central nervous system DNA fragmentation induced by the inhibition of nuclear factor kappa B.

Authors:  G Taglialatela; J A Kaufmann; A Trevino; J R Perez-Polo
Journal:  Neuroreport       Date:  1998-02-16       Impact factor: 1.837

6.  Short and long-term immunosuppressive effects of clozapine and haloperidol.

Authors:  I Leykin; R Mayer; M Shinitzky
Journal:  Immunopharmacology       Date:  1997-08

7.  Synthetic inhibitors of the multicatalytic proteinase complex (proteasome).

Authors:  S Wilk; M E Figueiredo-Pereira
Journal:  Enzyme Protein       Date:  1993

8.  Kinetic mechanism of activation by cardiolipin (diphosphatidylglycerol) of the rat liver multicatalytic proteinase.

Authors:  I Ruiz de Mena; E Mahillo; J Arribas; J G Castaño
Journal:  Biochem J       Date:  1993-11-15       Impact factor: 3.857

9.  An inhibitor of the chymotrypsin-like activity of the multicatalytic proteinase complex (20S proteasome) induces arrest in G2-phase and metaphase in HeLa cells.

Authors:  C Wójcik; D Schroeter; M Stoehr; S Wilk; N Paweletz
Journal:  Eur J Cell Biol       Date:  1996-06       Impact factor: 4.492

10.  A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B.

Authors:  E B Traenckner; S Wilk; P A Baeuerle
Journal:  EMBO J       Date:  1994-11-15       Impact factor: 11.598

View more
  1 in total

1.  Small Molecule Modulation of Proteasome Assembly.

Authors:  Evert Njomen; Pawel A Osmulski; Corey L Jones; Maria Gaczynska; Jetze J Tepe
Journal:  Biochemistry       Date:  2018-06-27       Impact factor: 3.162

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.